BRIEF published on 10/16/2024 at 15:21, 1 year 8 months ago Nombre de droits de vote et d'actions de Derichebourg au 30 juin 2024 Droits De Vote Capital Social Actions 30 Juin 2024 Derichebourg
BRIEF published on 10/16/2024 at 15:21, 1 year 8 months ago Number of voting rights and shares of Derichebourg as of June 30, 2024 Share Capital Voting Rights Actions June 30, 2024 Derichebourg
BRIEF published on 10/16/2024 at 15:07, 1 year 8 months ago Turkiye Garanti Bankasi A.S. Secures CMB Approval for Global Bond Issuance Bond Issuance Turkiye Garanti Bankasi Foreign Markets CMB Approval GMTN Program
BRIEF published on 10/16/2024 at 15:07, 1 year 8 months ago Turkiye Garanti Bankasi AS obtient l'approbation de la CMB pour l'émission d'obligations mondiales Emission D'obligations Marchés Étrangers Programme GMTN Banque De Garantie De Turquie Approbation CMB
BRIEF published on 10/16/2024 at 15:06, 1 year 8 months ago Ful. CashPay Partners with BeneStream to Enhance Healthcare Access Healthcare Access Financial Assistance BeneStream Partnership Essential Workers Public Healthcare Programs
BRIEF published on 10/16/2024 at 15:06, 1 year 8 months ago CashPay s'associe à BeneStream pour améliorer l'accès aux soins de santé Accès Aux Soins De Santé Aide Financière Partenariat BeneStream Travailleurs Essentiels Programmes De Santé Publique
BRIEF published on 10/16/2024 at 15:05, 1 year 8 months ago Catch and Freelancers Union Expand Health Insurance for US Freelancers Health Insurance Independent Workers Freelancers Union Open Enrollment Catch
BRIEF published on 10/16/2024 at 15:05, 1 year 8 months ago Catch et le syndicat des freelances étendent l'assurance maladie aux freelances américains Assurance Maladie Travailleurs Indépendants Syndicat Des Travailleurs Indépendants Inscriptions Ouvertes Attraper
BRIEF published on 10/16/2024 at 15:05, 1 year 8 months ago Athos Therapeutics Reports Promising Phase 1 Results for AI-Developed ATH-063 Phase 1 Trial Autoimmune Diseases AI Drug Development ATH-063 Regulatory T Cells
BRIEF published on 10/16/2024 at 15:05, 1 year 8 months ago Athos Therapeutics annonce des résultats prometteurs de la phase 1 de son ATH-063 développé par IA Maladies Auto-immunes Essai De Phase 1 ATH-063 Cellules T Régulatrices Développement De Médicaments Par IA
Published on 06/27/2026 at 16:50, 20 hours 45 minutes ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 11 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 13 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 14 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 14 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/27/2026 at 00:05, 1 day 13 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 13 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 13 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 13 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 1 day 14 hours ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
